Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01688986 · ClinicalTrials.gov registry record
Environmental Polymorphisms Registry Health and Exposures Survey
A clinical trial of Asthma and Diabetes, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- Completed
- Registry status
- 9,000
- Enrollment target
- 1
- Study location
NCT01688986 is a study of Asthma and Diabetes that has completed, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 9,000 participants, above the 1,539-participant average among 374 other Asthma trials with a reported enrollment target (485% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01688986, a study of Asthma and Diabetes, has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- COMPLETED
- Registry status
- 9,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The Environmental Polymorphisms Registry (EPR) Health and Exposure Survey is designed to gather health, family history of disease, environmental exposures and lifestyle data on adult EPR subjects. The EPR is a registry established to collect and store DNA samples from 20,000 volunteers from North Carolina and to serve as a resource to scientist investigating genotype-driven translational research of chronic conditions. Under this new protocol, we will administer a health and exposures survey to all EPR subjects. The information collected in the survey will be used to better characterize the EPR population thus making it more useful to NIEHS researchers. The survey contains approximately 200 questions. Data from the survey will help researchers develop hypotheses, design follow-up studies, and select appropriate subjects. The survey will be administered to EPR subjects using a modified version of the Dillman Total Design Method (TDM) for surveys. This method requires following specific time-dependent steps for survey administration that incorporate both self- and phone administration and other types of phone and mail contact. The goal of TDM is to maximize subject response rates.
Conditions Studied
Study Locations (1)
North Carolina
- NIEHS Clinical Research Unit (CRU) - Research Triangle Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,000 participants |
| Start Date | 2012-08-25 |
| Est. Completion | 2016-11-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01688986
The ClinicalTrials.gov registry entry for NCT01688986 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,539-participant average among 374 other Asthma trials with a reported enrollment target (485% higher). The listed sponsor is National Institute of Environmental Health Sciences (NIEHS), which has 145 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Asthma appearing as the primary indexed condition, and to 0 interventions.
NCT01688986 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT01688986 about?
NCT01688986 is a clinical study titled "Environmental Polymorphisms Registry Health and Exposures Survey". The Environmental Polymorphisms Registry (EPR) Health and Exposure Survey is designed to gather health, family history of disease, environmental exposures and lifestyle data on adult EPR subjects. The EPR is a registry established to collect and store DNA samples from 20,000 volunteers from North Ca...
What is the current status of trial NCT01688986?
This trial is currently completed. The enrollment target is 9,000 participants. The study started on 2012-08-25. Estimated completion is 2016-11-22.
What conditions does trial NCT01688986 study?
This clinical trial studies the following conditions: Asthma, Diabetes, Heart Disease.
Who is sponsoring clinical trial NCT01688986?
This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01688986 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.